Latest News
From the Journals
Blood transfusions are dropping in U.S. hospitals
The frequency of red blood cell transfusions declined between 2011 and 2014, but what’s driving the change?
Physician Resources
Phase 2 study tests low-dose maintenance therapy for ALL
The trial is expected to enroll 40 adult ALL patients in complete remission with positive minimal residual disease.
From the Journals
NASH rapidly overtaking hepatitis C as cause of liver cancer
The analysis is based on National Health and Nutrition Examination Survey and the Organ Procurement and Transplantation Network data.
News
FDA approves abemaciclib plus aromatase inhibitor as initial therapy
Abemaciclib plus an aromatase inhibitor was approved as initial endocrine-based therapy in women with HR-positive, HER2-negative metastatic breast...
Conference Coverage
High objective response rate, OS seen with ATA129 in PTLD
SALT LAKE CITY, UTAH – The findings confirm those from prior single-center studies.
Feature
Evaluations of Medicaid experiments by states, CMS are weak, GAO says
“Demonstration programs have been used since the 1990s to advance policy agenda for whoever holds power in Washington and not designed to test an...
From the Journals
Baseline stress signals need for psychological help in CLL
Be on the lookout for cancer-specific stress when treating chronic lymphocytic leukemia.
Conference Coverage
VIDEO: U.S. melanoma incidence hits all-time high
Annual U.S. incidence rates of invasive and in situ melanoma steadily climbed to a new high of 178,560 cases in 2018.
Conference Coverage
‘Remarkable’ survival seen with pretransplant JAK inhibitor
SALT LAKE CITY – Pretransplant JAK inhibitor therapy may improve posttransplant survival in patients with myelofibrosis, according to a phase 2...
Feature
Will Indiana Medicaid work requirements pass legal muster?
Indiana’s waiver requires certain Medicaid recipients to work or volunteer at least 20 hours a week to qualify for health care coverage.
Feature
Hospital chemo carries higher price tag than the office
More patients are getting chemotherapy in the hospital, even though the price is twice as high.